Hussman Econometrics Advisors »

Crispr Therapeutics shares owned by Hussman Econometrics Advisors

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Hussman Econometrics Advisors from 13F filings

Historical chart of Hussman Econometrics Advisors investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by Hussman Econometrics Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by Hussman Econometrics Advisors

Quarter filed Position value Share count Share price at filing
2023-09-30 $422k 9.3k 45.39
2023-06-30 $522k 9.3k 56.14
2023-03-31 $751k 17k 45.23
2022-12-31 $675k 17k 40.65
2022-09-30 $680k 10k 65.38
2022-06-30 $1.3M 21k 60.77
2022-03-31 $653k 10k 62.79
2021-12-31 $788k 10k 75.77
2021-09-30 $1.4M 12k 111.94
2021-06-30 $1.5M 9.3k 161.94
2021-03-31 $439k 3.6k 121.94
2020-12-31 $1.6M 10k 153.14
2020-09-30 $2.6M 31k 83.63
2020-06-30 $1.1M 15k 73.49
2020-03-31 $651k 15k 42.41
2019-12-31 $624k 10k 60.88